Dominantly inherited ataxias. Part I

Journal of Clinical Neuroscience

Volumn 5, Issue 3, 1998, Pages 257-264

  Storey, Elsdon ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005913855     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(98)90059-5     Document Type: Review

References (76)

1. Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of eleven families, including descendants of 'the Drew family of Walworth'. Brain 1982; 105: 1-28.
2. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983; i: 1151-1155.
3. Harding AE. The Hereditary Ataxias and Related Disorders. Edinburgh: Churchill Livingstone, 1984: 148-58.
4. Greenfield JG. The Spino-Cerebellar Degenerations. Oxford: Blackwell, 1954: 19-20; 35-66.
5. Konigsmark BW, Weiner LP. The olivopontocerebellar atrophies: a review. Medicine (Baltimore) 1970; 49: 227-241.
6. Subramony SH, Currier RD. The classification of familial ataxias. In: JMBV de Jong (ed). Handbook of Clinical Neurology, Vol 16 (60): Hereditary Neuropathies and Spinocerebellar Atrophies. Amsterdam: Elsevier, 1991: 271-284.
7. Giunti P, Sweeney MG, Spadaro M et al. The trinucleotide repeat expansion on chromosome 6p (SCA1) in autosomal dominant cerebellar ataxias. Brain 1994; 117: 645-649.
8. Waters CH, Takahashi H, Wilhelmsen KC et al. Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women. Neurology 1993; 43: 1555-1558.
9. Dürr A, Smadja D, Cancel G et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 1995; 118: 1573-1581.
10. Macintyre S, Sooman A. Non-paternity and prenatal genetic screening. Lancet 1991; 338: 869-871.
11. Brock DJH, Shrimpton AE. Non-paternity and prenatal genetic screening. (Letter) Lancet 1991; 338: 1151.
12. Le Roux M-G, Pascal O, Andre M-T, Herbert O, David A, Moisan J-P. Non-paternity and genetic counselling. (Letter) Lancet 1992; 340: 607.
13. Myers RH, MacDonald ME, Koroshetz WJ et al. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Nature Genet 1993; 5: 168-173.
14. Riess O, Laccone FA, Gispert S et al. SCA2 trinucleotide expansion in German SCA patients. Neurogenetics 1997; 1: 59-64.
15. Schöls L, Gispert S, Vorgerd M et al. Spinocerebellar ataxia type 2: genotype and phenotype in German kindreds. Arch Neurol 1997; 54: 1073-1080.
16. Ranum LPW, Lundgren JK, Schut LJ et al. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive or sporadic ataxia. Am J Human Genet 1995; 57: 603-608.
17. Schöls L, Vieira-Saecker AMM, Schöls S, Przuntek H, Epplen JT, Riess O. Trinucleotide expansion within the MJD 1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients. Human Mol Genet 1995; 4: 1001-1005.
18. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Human Genet 1997; 60: 842-850.
19. Cancel G, Dürr A, Didierjean O et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Human Mol Genet 1997; 6: 709-715.
20. Matsumura R, Futamura N, Fujimoto Y et al. Spinocerebellar ataxia type 6: molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology 1997; 49: 1238-1243.
21. Zoghbi H. CAG repeats in SCA6: anticipating new clues. Neurology 1997; 49: 1196-1209.
22. Gilman S, Quinn NP. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology 1996; 46: 1197-1199.
23. Wenning GK, Ben Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994; 117: 835-845.
24. Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997; 48: 384-393.
25. Enevoldson TP, Sanders MD, Harding AE. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy: a clinical and genetic study of eight families. Brain 1994; 117: 445-460.
26. Gouw L, Kaplan CD, Haines JH et al. Retinal degeneration characterises a spinocerebellar ataxia mapping to chromosome 3p. Nature Genet 1995; 10: 89-93.
27. Quinn N. Multiple system atrophy. In: CD Marsden, S Fahn (eds). Movement Disorders 3. Oxford: Butterworth-Heinemann, 1994: 262-281.
28. Soong B, Cheng C, Liu R, Shan D. Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol 1997; 41: 446-452.
29. Trottier Y, Lutz Y, Stevanin G et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995; 378: 403-406.
30. Chung M, Ranum LPW, Duvick LA, Servadio A, Zoghbi HY, Orr HT. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type 1. Nature Genet 1993; 5: 254-258.
31. Matilla T, Volpini V, Genis D et al. Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias. Human Molec Genet 1993; 2: 2123-2128.
32. Jodice C, Malaspina P, Persichetti F et al. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia 1. Am J Human Genet 1994; 54: 959-965.
33. Pulst S-M, Nechiporuk A, Starkman S. Anticipation in spinocerebellar ataxia type 2 (Letter). Nature Genet 1993; 5: 8-10.
34. Belal S, Cancel G, Stevanin G et al. Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. Neurology 1994; 44: 1423-1426.
35. Maruyama H, Nakamura S, Matsuyama Z et al. Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Human Mol Genet 1995; 4: 807-812.
36. Takiyama Y, Igarashi S, Rogaeva EA et al. Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Human Mol Genet 1995; 4: 1137-1146.
37. Dürr, A, Stevanin G, Cancel G et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996; 39: 490-499.
38. Ranum LPW, Schut LJ, Lundgren JK, Orr HT, Livingston DM. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nature Genet 1994; 8: 280-284.
39. Benomar A, Krols L, Stevanin G et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nature Genet 1995; 10: 84-88.
40. Flanigan K, Gardner K, Alderson K et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q 22.1. Am J Human Genet 1996; 59: 392-399.
41. Stevanin G, Dürr A, David G et al. Clinical and molecular features of spinocerebellar ataxia type 6. Neurology 1997; 49: 1243-1246.
42. Matsuyama Z, Kawakami H, Maruyama H et al. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (sca6). Human Mol Genet 1997; 6: 1283-1287.
43. Jodice C, Mantuano E, Veneziano L et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNAIA gene on chromosome 19p. Human Mol Genet 1997; 6; 1973-1978.
44. Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993; 43: 791-794.
45. Geschwind DH, Perlman S, Figueroa KP, Karrim J, Baloh RW, Pulst ST. Spinocerebellar ataxia type 6: frequency of the mutation and genotype correlations. Neurology 1997; 49: 1247-1251.
46. Doyu M, Sobue G, Mukai E et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992; 32: 707-710.
47. Suzuki Y, Sasaki H, Wakisaka A et al. Spinocerebellar ataxia 1 (SCA1) in the Japanese: analysis of CAG trinucleotide repeat expansion and instability of the repeat for paternal transmission. Jpn J Human Genet 1995; 40: 131-143.
48. Komure O, Sano A, Nishino N et al. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 1995; 45: 143-149.
49. Wexler NS, Young AB, Tanzi RE et al. Homozygotes for Huntington's disease. Nature 1987; 326: 194-197.
50. Myers RH, Leavitt J, Farrer LA et al. Homozygote for Huntington disease. Am J Human Genet 1989; 45: 615-618.
51. Kremer B, Goldberg P, Andrew SE et al. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. New Engl J Med 1994; 330: 1401-1406.
52. Goldfarb LG, Vasconcelos O, Platonov FA et al. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 1996; 39: 500-506.
53. Lerer I, Merims D, Abeliovich D, Zlotogora J, Gadoth N. Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Human Genet 1996; 4: 3-7.
54. Sato K, Kashihara K, Okada S et al. Does homozygosity advance the onset of dentatorubral-pallidoluysian atrophy? Neurology 1995; 45: 1934-1936.
55. 1A - voltage-dependent calcium channel. Nature Genet 1997; 15: 62-69.
56. Trottier Y, Devys D, Imbert G et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet 1995; 10: 104-110.
57. Sharp AH, Loev SJ, Schilling G et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995; 14: 1065-1074.
58. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nature Genet 1995; 10: 99-103.
59. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet 1995; 10: 94-98.
60. Ueno S, Kondoh K, Kotani Y et al. Somatic mosaicism of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA). Human Mol Genet 1995; 4: 663-666.
61. Nishiyama K, Murayama S, Goto J et al. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Ann Neurol 1996; 40: 776-781.
62. Li X-J, Li S-H, Sharp AH et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995; 378: 398-402.
63. Burke JR, Enghild JJ, Martin ME et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996; 2: 347-350.
64. Kalchman MA, Graham RK, Xia G et al. Huntingtin is ubiquinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 1996; 271: 19385-19394.
65. Kalchman MA, Koide HB, McCutcheon K et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet 1997; 16: 44-53.
66. Wanker EE, Rovira C, Scherzinger E et al. HIP-1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Human Mol Genet 1997; 6: 487-495.
67. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 1996; 13: 196-202.
68. Goldberg YP, Nicholson DW, Rasper DM et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 1996; 13: 442-449.
69. St. George-Hyslop P, Rogaeva E, Huterer J et al. Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14. Am J Hum Genet 1994; 55: 120-125.
70. Davies, SW, Turmaine M, Cozens BA et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537-548.
71. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994; 91: 5355-5358.
72. Scherzinger E, Lurz R, Turmaine M et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997; 90: 549-558.
73. Paulson HL, Perez MK, Trottier Y et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
74. Skinner PJ, Koshy BT, Cummings CT et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389: 971-974.
75. Roizin L, Stellar S, Liu JC. Neuronal nuclear-cytoplasmic changes in Huntington's chorea: electron microscope investigations. Adv Neurol 1979; 23: 95-122.
76. Matilla A, Koshy BT, Cummings CT, Isobe T, Orr HT, Zoghbi HY. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 1997; 389: 974-978.